SEC Form 4 · accession 0001493152-18-018024
ONCOSEC MEDICAL Inc · ONCS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel J. O'Connor
Officer — CEO and President · Director
Period of report
Dec 24, 2018
Accepted (ET)
Dec 27, 2018 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444307
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 24, 2018 | A | 750,000 | $0.00 | A | 776,667 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This is a long-term equity incentive award of restricted stock which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.